S
CAPR icon

SignatureFD’s Capricor Therapeutics CAPR Stock Holding History

SignatureFD’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43K Buy
+101
New +$3.06K ﹤0.01% 3097
2025
Q2 		– Sell
-82
Closed -$778 – 3287
2025
Q1 		$778 Buy
+82
New +$1.14K ﹤0.01% 3097
2024
Q4 		– Sell
-393
Closed -$5.98K – 3324
2024
Q3 		$5.98K Hold
393
– – ﹤0.01% 2518
2024
Q2 		$1.88K Buy
+393
New +$2.19K ﹤0.01% 2770

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SignatureFD's CAPR Position: Q2 2026 in Review

SignatureFD opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 101 shares worth $2.43K. The stake represents ﹤0.01% of the portfolio and ranks #3097 among its holdings. This is a return to the name: SignatureFD previously reported a position in CAPR as recently as Q1 2025.

SignatureFD first reported a position in CAPR in Q2 2024 and has held it in 4 quarters since. The position peaked at $5.98K in Q3 2024. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • SignatureFD held 101 shares of Capricor Therapeutics worth $2.43K as of Q2 2026.
  • Capricor Therapeutics was a new SignatureFD position in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3097 holding.
  • SignatureFD first reported a position in Capricor Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • SignatureFD's Capricor Therapeutics position peaked at $5.98K in Q3 2024.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.